Home Healthcare Biotechnology Advanced Therapy Medicinal Products (ATMP) Market

Advanced Therapy Medicinal Products (ATMP) Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy, Gene Therapy, CAR-T Therapy, Tissue Engineered Products), By Manufacturer (Biopharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), Digital Platform Providers) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: March 05, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Advanced Therapy Medicinal Products (ATMP) Market, By Therapy Type 2022-2034 (USD MILLION/ Units)
    1. Cell Therapy
    2. Gene Therapy
    3. CAR-T Therapy
    4. Tissue Engineered Products
  2. Advanced Therapy Medicinal Products (ATMP) Market, By Manufacturer 2022-2034 (USD MILLION/ Units)
    1. Biopharmaceutical Companies
    2. Contract Development and Manufacturing Organizations (CDMOs)
    3. Digital Platform Providers
  3. Regional Advanced Therapy Medicinal Products (ATMP) Market
    1. North America
      1. North America Advanced Therapy Medicinal Products (ATMP) Market By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
      2. North America Advanced Therapy Medicinal Products (ATMP) Market By Manufacturer 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. Contract Development and Manufacturing Organizations (CDMOs)
        3. Digital Platform Providers
      3. U.S.
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      4. Canada
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
    2. Europe
      1. Europe Advanced Therapy Medicinal Products (ATMP) Market By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
      2. Europe Advanced Therapy Medicinal Products (ATMP) Market By Manufacturer 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. Contract Development and Manufacturing Organizations (CDMOs)
        3. Digital Platform Providers
      3. U.K.
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      4. Germany
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      5. France
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      6. Spain
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      7. Italy
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      8. Russia
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      9. Nordic
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      10. Benelux
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      11. Rest of Europe
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
    3. APAC
      1. APAC Advanced Therapy Medicinal Products (ATMP) Market By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
      2. APAC Advanced Therapy Medicinal Products (ATMP) Market By Manufacturer 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. Contract Development and Manufacturing Organizations (CDMOs)
        3. Digital Platform Providers
      3. China
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      4. Korea
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      5. Japan
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      6. India
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      7. Australia
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      8. Singapore
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      9. Taiwan
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      10. South East Asia
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      11. Rest of Asia-Pacific
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
    4. Middle East and Africa
      1. Middle East and Africa Advanced Therapy Medicinal Products (ATMP) Market By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
      2. Middle East and Africa Advanced Therapy Medicinal Products (ATMP) Market By Manufacturer 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. Contract Development and Manufacturing Organizations (CDMOs)
        3. Digital Platform Providers
      3. UAE
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      4. Turkey
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      5. Saudi Arabia
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      6. South Africa
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      7. Egypt
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      8. Nigeria
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      9. Rest of MEA
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
    5. LATAM
      1. LATAM Advanced Therapy Medicinal Products (ATMP) Market By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
      2. LATAM Advanced Therapy Medicinal Products (ATMP) Market By Manufacturer 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical Companies
        2. Contract Development and Manufacturing Organizations (CDMOs)
        3. Digital Platform Providers
      3. Brazil
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      4. Mexico
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      5. Argentina
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      6. Chile
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      7. Colombia
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
      8. Rest of LATAM
        1. Cell Therapy
        2. Gene Therapy
        3. CAR-T Therapy
        4. Tissue Engineered Products
        5. Biopharmaceutical Companies
        6. Contract Development and Manufacturing Organizations (CDMOs)
        7. Digital Platform Providers
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.